| Editorial |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Are guidelines achievable today and in the future? Proceedings of a Satellite Symposium held at the 71st European Atherosclerosis Society Congress, Athens, Greece, 28 May 1999.
The most recent figures from the World Health Organization (WHO) show that coronary heart disease (CHD) remains the leading cause of mortality in the Western world and is the largest single cause of d...
|
Philip A Poole-Wilson
|
1-2
|
|
|
|
The revised joint guidelines
Abstract: There is a wealth of scientific evidence that lifestyle interventions and the use of drug therapies in patients with coronary heart disease (CHD) and individuals at high risk for developing ...
|
O. Faergeman
|
3-7
|
|
|
|
Are we treating to target?
Abstract: The identification of a number of independent risk factors for coronary heart disease (CHD) led to the development of guidelines for the prevention of CHD in an attempt to target these risk ...
|
L Erhardt
|
9-14
|
|
|
|
The benefit of aggressive lipid lowering
Abstract: The beneficial effects of lipid-lowering therapy for the primary and secondary prevention of coronary heart disease (CHD) have been conclusively demonstrated in large-scale clinical trials. ...
|
W.V Brown
|
15-19
|
|
|
|
Treating to target with statins
Abstract: Large-scale drug intervention trials have proven that cholesterol-lowering therapy reduces the risk of coronary events in a wide range of at-risk patient groups. This has led to a growing co...
|
P.J Barter
|
21-25
|
|
